Can pantoprazole and clonazepam be taken together?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Pantoprazole and Clonazepam Be Taken Together?

Yes, pantoprazole and clonazepam can be taken together safely, as there are no clinically significant drug interactions between these medications.

Evidence for Safety of Concurrent Use

The FDA drug label for pantoprazole explicitly states that in vivo drug interaction studies found no significant alterations in the pharmacokinetics of benzodiazepines when co-administered with pantoprazole 1. Specifically, pantoprazole does not significantly affect the kinetics of diazepam (a benzodiazepine in the same class as clonazepam) or its active metabolite, desmethyldiazepam 1.

Research studies confirm this lack of interaction:

  • A controlled study in 12 healthy volunteers receiving high-dose intravenous pantoprazole (240 mg daily for 7 days) with diazepam demonstrated no effect on diazepam clearance, elimination half-life, or metabolism to desmethyldiazepam 2.

  • Comprehensive reviews of pantoprazole's interaction profile consistently show it has a low potential to interact with the cytochrome P450 system, which metabolizes many medications including benzodiazepines 3, 4.

Mechanism Explaining Safety

Pantoprazole's metabolic pathway does not interfere with benzodiazepine metabolism. Pantoprazole is metabolized mainly by CYP2C19 and to minor extents by CYPs 3A4, 2D6, and 2C9 1. While clonazepam is metabolized by CYP3A4, pantoprazole has minimal inhibitory effect on this enzyme system 3, 4. This explains why no dose adjustments are needed for either medication when used together.

Clinical Considerations

Monitor for additive sedation effects, particularly in elderly patients or those with hepatic impairment. While the medications don't interact pharmacokinetically, clonazepam can cause sedation, morning drowsiness, confusion, and falls—especially in older adults 5, 6. Pantoprazole itself does not cause significant sedation 7.

Special populations requiring attention:

  • Elderly patients: Clonazepam is listed on the American Geriatrics Society Beers Criteria as potentially inappropriate in older adults due to increased fall risk 6, 8. The combination doesn't increase this risk beyond clonazepam alone, but heightened monitoring is warranted 8.

  • Patients with sleep apnea: Clonazepam at doses of 0.5-1.0 mg can worsen obstructive sleep apnea 5. This is a clonazepam-specific concern unrelated to pantoprazole co-administration.

Documented Clinical Use

The combination has been used safely in clinical practice. One case report documented a patient receiving both pantoprazole and clonazepam for gastroesophageal reflux and esophageal spasm without adverse interactions 9. This real-world evidence supports the safety profile established in controlled studies.

Common Pitfalls to Avoid

Do not confuse pantoprazole with omeprazole or esomeprazole, which have different interaction profiles. Pantoprazole specifically does not interfere with CYP2C19 activity to the same extent as omeprazole 10, 11, 4. This distinction is important when considering other drug interactions, though it doesn't affect the safety of combining pantoprazole with clonazepam.

Ensure appropriate dosing for each medication independently:

  • Pantoprazole: typically 40 mg once daily for acid-related disorders 7
  • Clonazepam: 0.25-2.0 mg at bedtime for conditions like REM sleep behavior disorder 5, 6

References

Research

Lack of pharmacokinetic interaction of pantoprazole with diazepam in man.

British journal of clinical pharmacology, 1996

Research

Lack of pantoprazole drug interactions in man: an updated review.

International journal of clinical pharmacology and therapeutics, 1996

Guideline

best practice guide for the treatment of rem sleep behavior disorder (rbd).

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2010

Guideline

management of rem sleep behavior disorder: an american academy of sleep medicine clinical practice guideline.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2023

Research

Pantoprazole: a proton pump inhibitor.

Clinical drug investigation, 2009

Guideline

polypharmacy management in older patients.

Mayo Clinic Proceedings, 2021

Research

A case of mediastinitis following botulinum toxin type A treatment for achalasia.

Nature clinical practice. Gastroenterology & hepatology, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.